AstraZeneca, J&J Resuming Phase III COVID-19 Vaccine Trials
AstraZeneca and Johnson & Johnson said they will resume Phase III trials of their COVID-19 vaccine candidates, at the recommendation of safety boards overseeing the studies that found no evidence the vaccines caused the patient illnesses that touched off pauses in recruitment.